Background Mitral valve repair (MVr) is the gold standard treatment for degenerative mitral regurgitation, yet there is ...

are still not being treated with any form of oral anticoagulant therapy. Meanwhile, a new portion of the PREFER registry study focusing on venous thromboembolism (VTE), such as pulmonary embolism ...

Included patients were receiving anticoagulation therapy at the time of preeducation knowledge assessment administration (July-August 2003). Patients unable to communicate through written or oral ...

Anticoagulation Therapy: A treatment that prevents blood clots from forming, often using medications such as warfarin or direct oral anticoagulants (DOACs). Direct Oral Anticoagulants (DOACs): A ...

Young patients who have undergone the Ross procedure for aortic valve disease have shown excellent long-term survival, the ...

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...

Tecarfarin is designed to be a superior and safer chronic oral anticoagulant therapy compared to warfarin for patients with implanted cardiac devices or rare cardiovascular conditions. Cadrenal ...

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Objective: To evaluate the potential drug interaction between oral corticosteroids and long-term warfarin therapy. Methods: A retrospective review was conducted of 387 medical records for active ...

Research indicates that women taking direct oral anticoagulants (DOACs ... treatment plans based on individual responses to anticoagulation therapy. Anticoagulants: Medications that prevent ...